We are live on ! Find out more
IIM

Illumine Investment Management Portfolio holdings

AUM $154M
1-Year Est. Return 52.22%
This Fund
S&P 500
This Quarter Est. Return
-1.31%
1 Year Est. Return
+52.22%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$122M
AUM Growth
+$592K
Cap. Flow
+$5.4M
Cap. Flow %
4.42%
Top 10 Hldgs %
31.72%
Holding
93
New
2
Increased
54
Reduced
16
Closed
3

Sector Composition

Rank Sector Weight
1 Technology 23.09%
2 Healthcare 15.98%
3 Financials 12.31%
4 Industrials 8.73%
5 Consumer Discretionary 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
26
Microsoft
MSFT
$3.66T
$1.6M 1.31%
4,255
+8
+0.2% +$3.26K
DT icon
27
Dynatrace
DT
$14.3B
$1.58M 1.3%
33,613
+278
+0.8% +$15.2K
CDNS icon
28
Cadence Design Systems
CDNS
$89B
$1.58M 1.29%
6,209
+151
+2% +$42K
VEEV icon
29
Veeva Systems
VEEV
$39.2B
$1.55M 1.27%
6,680
-3
-0% -$686
AME icon
30
Ametek
AME
$59.3B
$1.53M 1.25%
8,873
+119
+1% +$21.6K
RLY icon
31
State Street Multi-Asset Real Return ETF
RLY
$1.31B
$1.48M 1.21%
51,941
+1,455
+3% +$40.8K
GNTX icon
32
Gentex
GNTX
$4.93B
$1.48M 1.21%
63,385
+2,086
+3% +$53.3K
SNPS icon
33
Synopsys
SNPS
$79B
$1.48M 1.21%
3,441
+78
+2% +$37.9K
CORT icon
34
Corcept Therapeutics
CORT
$12.1B
$1.42M 1.16%
12,420
-8,061
-39% -$491K
DBEF icon
35
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.44B
$1.3M 1.06%
29,952
-7,906
-21% -$344K
QQQ icon
36
Invesco QQQ Trust
QQQ
$481B
$1.27M 1.04%
2,703
+50
+2% +$25.4K
POWL icon
37
Powell Industries
POWL
$7.58B
$1.19M 0.97%
20,961
-243
-1% -$16.9K
LMAT icon
38
LeMaitre Vascular
LMAT
$1.88B
$1.13M 0.93%
13,516
+84
+0.6% +$7.81K
MPTI icon
39
M-tron Industries
MPTI
$369M
$1.07M 0.88%
23,994
+584
+2% +$27.7K
NBIX icon
40
Neurocrine Biosciences
NBIX
$15.9B
$1.07M 0.87%
9,641
+139
+1% +$17.6K
JQUA icon
41
JPMorgan US Quality Factor ETF
JQUA
$8.57B
$1.03M 0.84%
18,194
+1,093
+6% +$63.8K
LMND icon
42
Lemonade
LMND
$4B
$958K 0.78%
30,478
+201
+0.7% +$6.92K
JPM icon
43
JPMorgan Chase
JPM
$971B
$844K 0.69%
3,441
TSM icon
44
TSMC
TSM
$2.23T
$838K 0.69%
5,046
GOOGL icon
45
Alphabet (Google) Class A
GOOGL
$4.2T
$784K 0.64%
5,070
AMPH icon
46
Amphastar Pharmaceuticals
AMPH
$850M
$769K 0.63%
26,530
+9,481
+56% +$303K
ITRI icon
47
Itron
ITRI
$4.49B
$757K 0.62%
7,227
+252
+4% +$26.4K
USMV icon
48
iShares MSCI USA Min Vol Factor ETF
USMV
$24.4B
$733K 0.6%
7,822
NWPX icon
49
NWPX Infrastructure Inc
NWPX
$1.1B
$732K 0.6%
17,734
+471
+3% +$21.9K
SSD icon
50
Simpson Manufacturing
SSD
$7.99B
$730K 0.6%
4,649
+1,061
+30% +$174K

Similar funds

Illumine Investment Management's Q1 2025 Portfolio in Review

As of Q1 2025, Illumine Investment Management held 93 positions worth $122M, up 0.49% from $122M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Illumine Investment Management deployed $5.4M of net new capital in Q1 2025, opening 2 new positions and adding to 54 existing holdings. Its largest new stake was Axcelis: 9,731 shares worth $483K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Corcept Therapeutics, an estimated $491K trimmed.

  • Illumine Investment Management's largest Q1 2025 buy was Axcelis: 9,731 shares worth $483K.
  • Illumine Investment Management added most to Guggenheim Strategic Opportunities Fund in Q1 2025, an estimated $629K increase.
  • Illumine Investment Management's biggest Q1 2025 reduction was Corcept Therapeutics, cutting an estimated $491K.
  • Illumine Investment Management fully exited Novo Nordisk in Q1 2025, selling an estimated $242K.
  • Illumine Investment Management's ten largest holdings make up 32% of its $122M portfolio in Q1 2025.
  • Illumine Investment Management opened 2 new positions and closed 3 in Q1 2025.
  • Illumine Investment Management's portfolio value rose 0.49% quarter-over-quarter to $122M.

Based on Illumine Investment Management's 13F filing for Q1 2025, filed 22 Apr 2025.